相关实验视频

Updated: May 6, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

GLUT3通过运输temozolomide和capecitabine来增强质母细胞瘤中的化学敏感性

Honglin Diao¹, Yuxin Sun¹, Xiaojia Zhou¹

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Cell death discovery

|August 14, 2025

概括

葡萄糖运输体GLUT3在多种质母细胞瘤 (GBM) 中促进化疗的吸收. 升级GLUT3可以提高对temozolomide (TMZ) 和capecitabine (CAPE) 的敏感性,从而改善GBM治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

多形质母细胞瘤 (GBM) 是一种具有侵略性的脑癌,由于耐化疗,预后不佳.
泰莫佐洛米德 (TMZ) 是对GBM的主要一线化疗,但其有效性受到抵抗机制的限制.
除了被动扩散之外,GBM中TMZ吸收的确切机制尚未完全理解.

研究的目的:

调查葡萄糖运输体GLUT3在GBM中化疗剂的吸收和疗效中的作用.
为了确定GLUT3是否调解GBM细胞中temozolomide (TMZ) 和capecitabine (CAPE) 的运输.
探索 GLUT3 向增强 GBM 化学敏感性的潜力.

主要方法:

使用GLUT3过度表达 (OE) 和淘汰 (KD) 的GBM细胞进行了吸收试验.
用分子对接,动力学模拟和微量热泳 (MST) 试验来验证GLUT3-TMZ/CAPE相互作用.
局部定向突变发生法确定了GLUT3中关键氨基酸,这些氨基酸参与了药物结合.
使用老鼠异种移植模型来评估GLUT3 OE对药物吸收和细胞毒性的体内影响.

主要成果:

过度表达GLUT3显著增强了TMZ和capecitabine在GBM细胞中的吸收和细胞毒性.
降低GLUT3降低了这些化疗剂的吸收.
分子建模和实验分析证实了GLUT3和TMZ/CAPE之间的直接相互作用.
在体内研究表明,在用GLUT3OE的异种移植模型中,药物吸收和疗效增加,特别是在禁食条件下.

结论:

GLUT3作为葡萄糖,TMZ和CAPE的多功能转运器,从而增加了GBM的化学敏感性.
这些发现挑战了GLUT3在葡萄糖运输中的独特作用,并强调了它在化疗吸收中的重要性.
向GLUT3表达或使用GLUT抑制剂与化疗结合使用可能是GBM患者的新治疗策略.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...